MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Walker, M. W.
Right arrow Articles by Miller, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Walker, M. W.
Right arrow Articles by Miller, R. J.

125I-neuropeptide Y and 125I-peptide YY bind to multiple receptor sites in rat brain

MW Walker and RJ Miller

Department of Pharmacological and Physiological Sciences, University of Chicago, Illinois 60637.

We describe the preparation of monoiodinated neuropeptide Y (Tyr1-125I- NPY) and monoiodinated peptide YY (Tyr36-125I-PYY). Using these ligands, we detected high, moderate, and low affinity receptor populations in rat brain. Only high and moderate affinity binding sites were suggested by saturation binding studies. Tyr1-125I-NPY bound to 8 +/- 3% of the sites with a Kd of 54 pM (Bmax = 19.4 fmol/mg of protein) and to 92 +/- 3% of the sites with a Kd of 0.92 nM (Bmax = 220.0 fmol/mg of protein). Tyr36-125I-PYY bound to 14 +/- 3% of the sites with a Kd of 23.5 pM (Bmax = 36.4 fmol/mg of protein) and to 86 +/- 3% of the sites with a Kd of 1.9 nM (Bmax = 220.1 fmol/mg of protein). The fragments NPY 13-36 and PYY 13-36 were able to compete with 10 pM Tyr1- 125I-NPY for essentially all the binding sites. The fragments were 1 to 2 orders of magnitude less potent than the native peptides. Approximately 50% of the moderate affinity sites, but not the high affinity sites, were reversibly "lost" in the presence of 5'-guanylyl imidophosphate [Gpp(NH)p], a nonhydrolyzable analog of GTP. Kinetic studies revealed that Tyr1-125I-NPY dissociation could be best described by three dissociation rates. The proportions of slow and intermediate dissociation matched the proportions of moderate and high affinity binding sites, respectively, as suggested by equilibrium studies. There also existed a phase of fast dissociation. When Gpp(NH)p was added during dissociation, the proportion of slow dissociation decreased to the same extent that the fast dissociation was increased. However, the proportion of intermediate dissociation did not change. We propose that rat brain contains a minor population of high affinity NPY binding sites with an intermediate dissociation rate and no sensitivity to Gpp(NH)p. There is also a major population of moderate affinity binding sites with a slow dissociation rate. A component of these sites can convert to a low affinity state with a fast dissociation rate. Gpp(NH)p enhances conversion by stabilizing the low affinity state, thereby producing a "loss" of moderate affinity binding.

Volume 34, Issue 6, pp. 779-792, 12/01/1988
Copyright © 1988 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
S. L. Parker, M. S. Parker, T. Sweatman, and W. R. Crowley
Characterization of G Protein and Phospholipase C-Coupled Agonist Binding to the Y1 Neuropeptide Y Receptor in Rat Brain: Sensitivity to G Protein Activators and Inhibitors and to Inhibitors of Phospholipase C
J. Pharmacol. Exp. Ther., July 1, 1998; 286(1): 382 - 391.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Renal Physiol.Home page
C. A. Blaze, P. J. Mannon, S. R. Vigna, A. R. Kherani, and B. A. Benjamin
Peptide YY receptor distribution and subtype in the kidney: effect on renal hemodynamics and function in rats
Am J Physiol Renal Physiol, October 1, 1997; 273(4): F545 - F553.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
A. N. van den Pol, K. Obrietan, G. Chen, and A. B. Belousov
Neuropeptide Y-Mediated Long-Term Depression of Excitatory Activity in Suprachiasmatic Nucleus Neurons
J. Neurosci., September 15, 1996; 16(18): 5883 - 5895.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
C Wahlestedt, E. Pich, G. Koob, F Yee, and M Heilig
Modulation of anxiety and neuropeptide Y-Y1 receptors by antisense oligodeoxynucleotides
Science, January 22, 1993; 259(5094): 528 - 531.
[Abstract] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1988 by the American Society for Pharmacology and Experimental Therapeutics